Linde PLC (LIN) operating KPIs

LINNasdaqIndustrial Inorganic ChemicalsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 16/3037% above fair value

$514.24+11.09 (+2.20%)

Close on Oct 30, 2026Market cap $237.05BP/E 34.1Yield 1.17%

KPIs

Operating metrics that drive Linde's business · fiscal year ends December 31

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Metric	Q3 2026 2026-09-30	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31

Total Project Backlog($M)2	10,800	11,100	9,900	10,000	10,000	10,300	10,300	10,400	10,100	7,900	8,300	8,500
Sale of Gas (SOG) Project Backlog($M)	7,900	8,100	7,100	7,300	7,100	7,100	7,000	7,100	7,000	4,700	4,900	4,900
Third-Party Sale of Plant / Equipment (SOP) Backlog($M)1	2,900	3,000	2,800	2,700	2,900	3,200	3,300	3,300	3,100	3,200	3,400	3,600
Linde Engineering Third-Party Quarterly Order Intake($M)	499	871	640	434	269	311	516	880		336	364	567
Remaining Performance Obligations (On-Site Long-Term Minimums)($M)2	66,000	64,000	64,000	62,000	62,000	61,000	58,000	58,000	59,000	50,000	48,000	48,000
Contract Assets — Current($M)	447	432	321	269	228	260	293	263	255	226	217	196
Contract Liabilities — Total Deferred Revenue & Progress Billings($M)2	2,447	2,413	2,456	2,515	2,533	2,494	2,399	2,292	2,791	2,820	2,901	2,950
Contract Liabilities — Current($M)	1,170	1,128	1,168	1,231	1,279	1,261	1,196	1,194	1,727	1,767	1,827	1,901
Contract Liabilities — Noncurrent($M)	1,277	1,285	1,288	1,284	1,254	1,233	1,203	1,098	1,064	1,053	1,074	1,049
Capital Expenditures — Project vs. Base Allocation($M)4	1,392	1,438	1,342	1,458	1,276	1,257	1,270	1,250	1,066	1,133	1,048	1,151
Project CapEx (Contractual Backlog Projects >$5M)($M)	750	780	653	760	636	614	634	594	493	515
Base CapEx (Maintenance, Cylinders, Small Growth & Non-Project)($M)	642	658	689	698	640	643	636	656	573	618	647	705
Full-Year CapEx Guidance — Low End($M)	5,500	5,500	5,000	5,000	5,000		5,000			4,000	4,000
Full-Year CapEx Guidance — High End($M)	6,000	6,000	5,500	5,500	5,500		5,500			4,500	4,500

Consolidated Sales Change YoY(%)5	2.0%	30.0%	8.0%		3.0%	3.0%			2.0%	1.0%	-2.0%
Underlying Organic Sales Growth YoY (Volume + Price/Mix)(%)2	5.0%	4.0%	3.0%	3.0%	2.0%	1.0%	1.0%	2.0%		3.0%	1.0%	4.0%
Volume Contribution YoY(%)	2.0%	2.0%	1.0%	1.0%	0.0%	-1.0%			0.0%	0.0%	-1.0%
Price / Mix Attainment YoY(%)	3.0%	2.0%	2.0%	2.0%	2.0%	2.0%			2.0%	3.0%	2.0%
Cost Pass-Through Contribution YoY (Natural Gas & Power)(%)	2.0%	4.0%	0.0%		0.0%	1.0%			-1.0%	-1.0%	-2.0%
Currency Translation Impact YoY(%)	0.0%	0.0%	5.0%		1.0%	0.0%			-1.0%	-2.0%	0.0%
Acquisitions / Divestitures Net Impact YoY(%)	0.0%	0.0%	1.0%		1.0%	1.0%			0.0%	0.0%	0.0%
Engineering Segment Contribution YoY(%)	1.0%	1.0%	-1.0%		-1.0%	0.0%			2.0%	1.0%	0.0%
EMEA Segment Sales Change YoY(%)6	7.0%	7.0%	7.0%		3.0%	3.0%	-3.0%		0.0%	-3.0%	-4.0%
EMEA Underlying Sales Growth YoY(%)	3.0%	1.0%	-2.0%	-2.0%	-1.0%	-1.0%
EMEA Volume Contribution YoY(%)	1.0%	-1.0%	-3.0%		-3.0%	-4.0%	-3.0%		-1.0%	-1.0%	-2.0%
EMEA Price / Mix Attainment YoY(%)	2.0%	2.0%	1.0%		2.0%	3.0%	2.0%		4.0%	3.0%	3.0%
EMEA Cost Pass-Through Contribution YoY(%)	3.0%	2.0%	-2.0%		-1.0%	0.0%	1.0%		-3.0%	-4.0%	-5.0%
EMEA Currency Translation Impact YoY(%)	0.0%	3.0%	10.0%		5.0%	4.0%	-3.0%		0.0%	-1.0%	0.0%
EMEA Acquisitions / Divestitures Impact YoY(%)	1.0%	1.0%	1.0%		0.0%	0.0%	0.0%		0.0%	0.0%	0.0%
APAC Segment Sales Change YoY(%)5	12.0%	13.0%	11.0%		1.0%	0.0%	-3.0%		5.0%	-2.0%	0.0%
APAC Underlying Sales Growth YoY(%)	8.0%	8.0%	6.0%	2.0%	-1.0%	-1.0%
APAC Price / Mix Attainment YoY(%)	3.0%	2.0%	0.0%		-1.0%	0.0%	0.0%		0.0%	0.0%	1.0%
APAC Cost Pass-Through Contribution YoY(%)	1.0%	2.0%	-1.0%		0.0%	-1.0%	0.0%		1.0%	1.0%	0.0%
APAC Currency Translation Impact YoY(%)	3.0%	3.0%	4.0%		-1.0%	0.0%	-2.0%		1.0%	-3.0%	-4.0%
APAC Acquisitions / Divestitures Impact YoY(%)	0.0%	0.0%	2.0%		3.0%	2.0%	0.0%		0.0%	0.0%	0.0%
Americas Segment Sales Change YoY (Legacy Basis — Incl. U.S. Homecare, through 2Q26)1
Americas Underlying Sales Growth YoY (Legacy Basis)(%)		4.0%	6.0%	4.0%	4.0%	4.0%	4.0%	3.0%		4.0%	2.0%	6.0%

Consolidated Sales by Gas Distribution Mode($M)4	9,404	9,289	8,781	8,764	8,615	8,495	8,112	8,282	8,356	8,267	8,100	8,302
Packaged Gas Sales (Cylinders, Specialty Gases & Welding Hardgoods)($M)1	3,147	3,168	3,037	3,023	3,033	2,976	2,821	2,861	2,935	2,940	2,887	2,857
Packaged Gas % of Consolidated Sales(%)	33.0%	34.0%	35.0%		35.0%	35.0%	35.0%		35.0%	36.0%	36.0%
Merchant Liquid Sales (Cryogenic Tanker Bulk Delivery, 3–7 Yr Contracts)($M)1	2,922	2,784	2,588	2,568	2,619	2,595	2,377	2,401	2,501	2,489	2,387	2,400
Merchant Liquid % of Consolidated Sales(%)	31.0%	30.0%	29.0%		30.0%	31.0%	29.0%		30.0%	30.0%	29.0%
On-Site Pipeline & Tonnage Sales (15–20 Yr Take-or-Pay Supply)($M)1	2,157	2,190	2,158	2,066	2,034	2,002	1,981	1,958	1,920	1,887	1,891	1,946
On-Site % of Consolidated Sales(%)	23.0%	24.0%	25.0%		24.0%	24.0%	24.0%		23.0%	23.0%	23.0%
Other Distribution / EPC Plant / Healthcare Service Sales($M)1	1,178	1,147	998	1,107	929	922	933	1,062	1,000	951	935	1,099
Other Mode % of Consolidated Sales(%)	13.0%	12.0%	11.0%		11.0%	10.0%	12.0%		12.0%	11.0%	12.0%
EMEA Sales by Distribution Mode($M)4	2,327	2,303	2,171	2,178	2,178	2,162	2,031	2,059	2,111	2,091	2,091	2,100
EMEA — Packaged Gas($M)	1,060	1,053	1,019	1,031	1,011	1,002	926	931	954	969	951	925
EMEA — Merchant Liquid($M)	758	763	719	727	736	726	671	684	704	691	686	684
EMEA — On-Site Pipeline($M)	470	480	425	409	424	426	426	428	441	412	441	476
EMEA — Other($M)	39	7	8	11	7	8	8	16	12	19	13	15
APAC Sales by Distribution Mode($M)4	1,950	1,870	1,701	1,726	1,741	1,655	1,539	1,668	1,716	1,657	1,591	1,639
APAC — On-Site Pipeline($M)	774	764	725	707	717	698	667	679	680	668	668	627
APAC — Merchant Liquid($M)	641	616	534	555	591	558	509	547	589	568	529	557
APAC — Packaged Gas($M)	424	402	363	357	375	350	316	335	371	348	322	344
APAC — Other($M)	111	88	79	107	58	49	47	107	76	73	72	111
Linde Engineering External Sales (EPC Plant Design & Construction)($M)	582	625	517	615	519	551	565	628	611	544	539	658
Americas Sales by Distribution Mode (Legacy Basis — Incl. U.S. Homecare, through 2Q26)($M)4		4,083	4,025	3,884	3,846	3,812	3,666	3,609	3,618	3,655	3,560	3,583
Americas (Legacy) — Packaged Gas (incl. Homecare)($M)		1,708	1,649	1,630	1,641	1,617	1,572	1,589	1,602	1,616	1,607	1,582
Americas (Legacy) — Merchant Liquid($M)		1,352	1,296	1,240	1,242	1,260	1,150	1,117	1,160	1,178	1,117	1,102
Americas (Legacy) — On-Site Pipeline($M)		946	1,008	950	893	878	888	851	799	807	782	843
Americas (Legacy) — Other($M)		77	72	64	70	57	56	52	57	54	54	56
Global Other Sales by Distribution Mode (Legacy Basis — Excl. U.S. Homecare, through 2Q26)($M)3		408	367	361	331	315	311	318	300	320	319	322
Global Other (Legacy) — Surface Technologies / Materials & Other($M)		350	322	310	275	257	257	259	244	261	257	259
Global Other (Legacy) — Merchant (Global Helium)($M)		53	39	46	50	51	47	53	48	52	55	57
Global Other (Legacy) — Packaged Gas($M)		5	6	5	6	7	7	6	8	7	7	6

Chemicals & Energy (Cyclical — Refining, Petrochemicals, Clean Hydrogen) — % of Industrial Gas Sales(%)2	22.0%	21.0%	22.0%	21.0%	20.0%	22.0%	22.0%	22.0%	21.0%	21.0%	21.0%	22.0%
Chemicals & Energy (Cyclical — Refining, Petrochemicals, Clean Hydrogen) — Organic YoY Sales Growth(%)	12.0%	2.0%	3.0%	2.0%	1.0%	4.0%	2.0%	0.0%	2.0%	5.0%	4.0%	6.0%
Chemicals & Energy (Cyclical — Refining, Petrochemicals, Clean Hydrogen) — Sequential QoQ Organic Sales Growth(%)	5.0%	4.0%	1.0%	2.0%	-5.0%	5.0%	0.0%	-1.0%	-1.0%	6.0%	-2.0%	-1.0%
Manufacturing (Cyclical — Industrial Fabrication, Aerospace, Automotive) — % of Industrial Gas Sales(%)2	21.0%	21.0%	21.0%	21.0%	21.0%	21.0%	21.0%	22.0%	22.0%	22.0%	22.0%	22.0%
Manufacturing (Cyclical — Industrial Fabrication, Aerospace, Automotive) — Organic YoY Sales Growth(%)	7.0%	5.0%	5.0%	2.0%	3.0%	0.0%	0.0%	4.0%	2.0%	4.0%	1.0%	8.0%
Manufacturing (Cyclical — Industrial Fabrication, Aerospace, Automotive) — Sequential QoQ Organic Sales Growth(%)	2.0%	4.0%	0.0%	0.0%	2.0%	2.0%	-1.0%	0.0%	-2.0%	3.0%	2.0%	-1.0%
Healthcare (Resilient — Hospital Medical Oxygen, Home Respiratory) — % of Industrial Gas Sales(%)2	15.0%	16.0%	16.0%	16.0%	16.0%	17.0%	17.0%	17.0%	17.0%	17.0%	17.0%	17.0%
Healthcare (Resilient — Hospital Medical Oxygen, Home Respiratory) — Organic YoY Sales Growth(%)	2.0%	2.0%	1.0%	1.0%	1.0%	1.0%	1.0%	0.0%	1.0%	-1.0%	0.0%	4.0%
Healthcare (Resilient — Hospital Medical Oxygen, Home Respiratory) — Sequential QoQ Organic Sales Growth(%)	1.0%	1.0%	0.0%	1.0%	1.0%	-1.0%	0.0%	1.0%	0.0%	0.0%	-1.0%	2.0%
Metals & Mining (Cyclical — Steel Oxygen/Argon, Non-Ferrous) — % of Industrial Gas Sales(%)2	12.0%	13.0%	13.0%	13.0%	13.0%	13.0%	13.0%	13.0%	13.0%	13.0%	14.0%	14.0%
Metals & Mining (Cyclical — Steel Oxygen/Argon, Non-Ferrous) — Organic YoY Sales Growth(%)	3.0%	4.0%	3.0%	1.0%	1.0%	0.0%	-3.0%	2.0%	0.0%	-2.0%	0.0%	0.0%
Metals & Mining (Cyclical — Steel Oxygen/Argon, Non-Ferrous) — Sequential QoQ Organic Sales Growth(%)	-1.0%	3.0%	1.0%	-2.0%	0.0%	3.0%	0.0%	-2.0%	-1.0%	0.0%	4.0%	-2.0%
Electronics (Resilient/Growth — Semiconductor Fabs, Ultra-Pure N2 & Specialty Gases) — % of Industrial Gas Sales(%)2	10.0%	10.0%	10.0%	10.0%	9.0%	9.0%	9.0%	9.0%	9.0%	9.0%	9.0%	9.0%
Electronics (Resilient/Growth — Semiconductor Fabs, Ultra-Pure N2 & Specialty Gases) — Organic YoY Sales Growth(%)	15.0%	18.0%	10.0%	7.0%	6.0%	-1.0%	6.0%	4.0%	9.0%	7.0%	1.0%	-4.0%
Electronics (Resilient/Growth — Semiconductor Fabs, Ultra-Pure N2 & Specialty Gases) — Sequential QoQ Organic Sales Growth(%)	1.0%	7.0%	1.0%	5.0%	4.0%	-1.0%	2.0%	2.0%	-1.0%	7.0%	0.0%	3.0%
Food & Beverage (Resilient — Cryogenic Freezing N2 & Beverage CO2) — % of Industrial Gas Sales(%)2	9.0%	9.0%	9.0%	9.0%	10.0%	9.0%	9.0%	9.0%	10.0%	10.0%	9.0%	9.0%
Food & Beverage (Resilient — Cryogenic Freezing N2 & Beverage CO2) — Organic YoY Sales Growth(%)	3.0%	3.0%	5.0%	5.0%	3.0%	3.0%	4.0%	6.0%	7.0%	8.0%	6.0%	9.0%
Food & Beverage (Resilient — Cryogenic Freezing N2 & Beverage CO2) — Sequential QoQ Organic Sales Growth(%)	3.0%	5.0%	-1.0%	-3.0%	3.0%	6.0%	-1.0%	-4.0%	3.0%	7.0%	1.0%	-4.0%

Adjusted After-Tax Return on Capital (Non-GAAP ROC)(%)2	23.5%	23.5%	23.8%	24.2%	24.6%	25.1%	25.7%	25.9%	25.8%	25.7%	25.6%
4-Quarter Trailing Adjusted NOPAT($M)1	8,580	8,437	8,286	8,137	8,062	7,968	7,890	7,839	7,697	7,560	7,450	7,305
Quarterly Adjusted NOPAT($M)	2,225	2,182	2,112	2,061	2,082	2,031	1,963	1,986	1,988	1,953	1,912	1,844
5-Quarter Average Ending Adjusted Capital($M)1	36,497	35,971	34,835	33,597	32,797	31,786	30,701	30,248	29,865	29,404	29,144	28,774
Ending Adjusted Capital($M)	37,623	37,618	36,323	35,547	35,374	34,992	31,938	30,133	31,550	30,315	29,571	29,673
Reported GAAP After-Tax Return on Capital(%)2	11.8%	12.2%	12.2%	12.1%	12.6%	12.2%	12.3%	12.3%	12.1%	12.1%	12.0%	11.8%
4-Quarter Trailing Reported NOPAT($M)1	7,379	7,607	7,446	7,252	7,440	7,074	6,970	6,931	6,753	6,727	6,626	6,492
Quarterly Reported NOPAT($M)	1,793	2,018	1,947	1,621	2,021	1,857	1,753	1,809	1,655	1,753	1,714	1,631
5-Quarter Average Ending Reported Capital($M)1	62,624	62,098	60,962	59,725	58,925	57,914	56,830	56,377	55,994	55,535	55,277	54,910
Ending Reported Capital($M)	63,750	63,745	62,450	61,674	61,502	61,120	58,066	56,261	57,678	56,443	55,700	55,804
Net Debt (Total Debt Less Cash & Equivalents)($M)1	22,755	23,115	22,358	21,933	21,416	21,134	18,603	16,773	17,075	16,892	15,471	14,709
Adjusted Net Debt (Excl. Linde AG Debt Fair-Value Step-Up)($M)	22,752	23,112	22,355	21,930	21,412	21,130	18,599	16,769	17,071	16,888	15,466	14,702
Segment Sales — Recast 3Q26 Structure (U.S. Homecare in Global Other)($M)5	9,404	9,289	8,781	8,764	8,615	8,495	8,112	8,282	8,356	8,267	8,100	8,302
Americas Segment Sales (Recast — Excl. U.S. Homecare)($M)	3,601	3,504	3,448	3,303	3,253	3,224	3,080
EMEA Segment Sales($M)	2,327	2,303	2,171	2,178	2,178	2,162	2,031	2,059	2,111	2,091	2,091	2,100
APAC Segment Sales($M)	1,950	1,870	1,701	1,726	1,741	1,655	1,539	1,668	1,716	1,657	1,591	1,639
Engineering Segment Sales($M)	582	625	517	615	519	551	565	628	611	544	539	658
Global Other Sales (Recast — Incl. U.S. Homecare / Lincare)($M)	944	987	944	942	924	903	897
Segment / Adjusted Operating Profit — Recast 3Q26 Structure($M)9	2,763	2,744	2,630	2,585	2,558	2,556	2,438	2,480	2,477	2,422	2,341	2,272
Americas Operating Profit (Recast — Excl. U.S. Homecare)($M)	1,263	1,219	1,200	1,122	1,124	1,116	1,039
EMEA Operating Profit($M)	817	823	784	772	781	780	722	686	703	704	687	615
APAC Operating Profit($M)	534	531	477	502	490	490	451	500	497	474	447	452
Engineering Operating Profit($M)	107	100	101	103	101	90	114	106	108	96	100	119
Global Other Operating Profit (Recast — Incl. U.S. Homecare)($M)	42	71	68	86	62	80	112
Adjusted Operating Margin(%)	29.4%	29.5%	30.0%	29.5%	29.7%	30.1%	30.1%	29.9%	29.6%	29.3%	28.9%	27.4%
Reported GAAP Operating Margin(%)	22.9%	27.5%	27.8%	23.0%	27.5%	27.7%	26.9%	27.4%	25.0%	26.4%	25.9%	24.4%
Linde AG Merger Purchase Accounting Amortization Impact on Op. Profit($M)	188	190	191	338	202	202	199	0	0	1	2	1
Cost Reduction Program & Restructuring Charges in Op. Profit($M)	425	0	0	229	-5	0	55	0	145	0	0	-2
Adjusted EBITDA (Non-GAAP)($M)3	3,620	3,572	3,449	3,410	3,377	3,351	3,213	3,244	3,253	3,206	3,116	3,037
Adjusted EBITDA Margin(%)	38.5%	38.5%	39.3%	38.9%	39.2%	39.4%	39.6%	39.2%	38.9%	38.8%	38.5%	36.6%
Reported EBITDA (IR Table Definition)($M)	34	38	39	34	39	39	39	39	37	39	38	36
Adjusted Depreciation & Amortization (Excl. Linde AG Step-Up)($M)	777	773	760	764	759	744	719	707	720	721	709	708
Adjusted Diluted EPS (Non-GAAP) & Forward Guidance($)8	4.59	4.50	4.33	4.20	4.21	4.09	3.95	3.97	3.94	3.85	3.75	3.59
Adjusted Net Income — Linde plc($M)	2,122	2,089	2,019	1,968	1,987	1,937	1,880	1,899	1,896	1,859	1,821	1,753
Adjusted Effective Tax Rate(%)	23.8%	23.9%	23.5%	24.3%	22.7%	24.3%	23.5%	23.7%	23.6%	23.5%	22.7%	22.8%
Reported GAAP Effective Tax Rate(%)	21.1%	24.0%	23.5%	23.9%	18.0%	24.4%	23.4%	23.6%	24.1%	23.5%	22.3%	23.0%
Company-Reported Free Cash Flow (OCF Less CapEx)($M)	1,777	833	898	1,572	1,672	954	891	1,559	1,665	796	906	1,576
Next-Quarter Adjusted Diluted EPS Guidance — Low End($)	4.40	4.45	4.40	4.20	4.10	4.10	3.95			3.82	3.70
Next-Quarter Adjusted Diluted EPS Guidance — High End($)	4.50	4.55	4.50	4.30	4.20	4.20	4.05			3.92	3.80
Full-Year Adjusted Diluted EPS Guidance — Low End($)	17.82	17.70	17.60	17.40	16.35		16.20			15.40	15.30	15.25
Full-Year Adjusted Diluted EPS Guidance — High End($)	17.92	17.90	17.90	17.90	16.45		16.50			15.60	15.60	15.65
Americas Segment Sales (Legacy Basis — Incl. U.S. Homecare, through 2Q26)($M)		4,083	4,025	3,884	3,846	3,812	3,666	3,609	3,618	3,655	3,560	3,583
Global Other Sales (Legacy Basis — Excl. U.S. Homecare, through 2Q26)($M)		408	367	361	331	315	311	318	300	320	319	322
Americas Operating Profit (Legacy Basis — Incl. U.S. Homecare, through 2Q26)($M)		1,272	1,272	1,202	1,199	1,209	1,137	1,150	1,153	1,159	1,088	1,075
Global Other Operating Profit (Legacy Basis — Excl. U.S. Homecare, through 2Q26)($M)		18	-4	6	-13	-13	14	38	16	-11	19	11

Property, Plant & Equipment — Gross Carrying Value by Asset Class1
Property, Plant & Equipment — Net($M)	29,830	29,170	28,564	28,260	27,535	26,928	25,710	24,775	25,124	24,575	24,418	24,552
Inventories by Stage($M)2	2,129	2,122	2,079	2,055	2,128	2,122	1,984	1,946	2,087	2,094	2,100	2,115
Finished Goods (Liquefied/Packaged Gases & Hardgoods)($M)	1,177	1,159	1,144	1,179	1,185	1,171	1,102	1,046	1,075	1,079	1,086	1,111
Raw Materials & Supplies($M)	541	554	545	530	533	539	499	529	580	593	604	614
Treasury Stock Held, Buybacks, SBC, Pension & Tax Reserves (Treasury Shares)(M)5	31.7	29.8	28.2	27.1	23.8	21.9	19.5	17.5	14.6	13.3	10.1	8.32
Treasury Stock — Carrying Cost($M)	13,862	12,928	12,104	11,561	10,177	9,242	8,154	7,252	5,927	5,309	3,922	3,133
Ordinary Share Repurchases (Gross/Cost Method)($M)	953	873	791	1,401	992	1,114	1,099	1,344	670	1,407	1,038	1,003
Share-Based Compensation Expense($M)	44	19	41	31	45	46	42	40	42	40	38	39
Restructuring Charges($M)	425	0	0	229	-11	0	55	0	145	0	0	-2
Defined Benefit Service Cost($M)	20	20	20		21	21	20		21	21	21

Linde Bangladesh Limited (DSE: LINDEBD, 60%-Owned) — Revenue (BDT Million)(M)6	642	627	592	606	588	537	550
Linde Bangladesh — Gross Profit (BDT Million)(M)	287	290	273		278	239	258
Linde Bangladesh — Operating Profit (BDT Million)(M)	90.8	125	141		100	95.9	97.0
Linde Bangladesh — Profit Before Tax (BDT Million)(M)	95.4	130	141	76.1	118	128	111
Linde Bangladesh — Net Profit After Tax (BDT Million)(M)	79.6	84.6	110	57.8	98.6	107	80.6
Linde Bangladesh — Diluted EPS (BDT per Share)(×)	5.23	5.56	7.22	3.80	6.48	7.03	5.29
Linde Bangladesh — Net Asset Value per Share (BDT)(×)	218.08	213.09	217.53
Linde India Limited (NSE: LINDEINDIA, 75%-Owned) — Revenue from Operations (INR Million)(M)8		6,944	6,143	7,010	6,442	5,711	5,919	6,059	6,442		6,301	7,062
Linde India — Gases, Related Products & Services Segment Revenue (INR Million)(M)		5,444	5,238	5,085	5,604	4,997	5,159	5,085	5,604		4,977	5,186
Linde India — Project Engineering Segment Revenue (INR Million)(M)		2,246	2,233	2,630	2,250	2,540	2,710	2,630	2,250		2,949	2,871
Linde India — Power & Fuel Expense (ASU Electricity Cost, INR Million)(M)		11,297	1,308	1,164	415	1,288	1,258	1,361	1,343	1,266	1,273	1,133
Linde India — Gases Segment EBIT (INR Million)(M)		1,322	1,318	5,101	2,159	1,288	1,518	1,275	1,275		1,172	1,307
Linde India — Project Engineering Segment EBIT (INR Million)(M)		235	128	550	237	273	192	362	155		271	333
Linde India — Profit Before Tax (INR Million)(M)		1,397	1,160	2,448	2,283	1,443	1,613	1,570	2,283	1,497	1,425	1,592
Linde India — Net Profit After Tax (INR Million)(M)		1,046	774	1,933	1,710	1,072	1,184	1,163	1,710	1,115	1,054	1,201
Linde India — Gases Segment Assets (INR Million)(M)		50,558	50,318	34,629	46,345	45,619	5,503	34,629	46,345		4,452	26,878

Consolidated GAAP Sales (DB Income Statement)($M)15	9,404	9,289	8,781	8,764	8,615	8,495	8,112	8,282	8,356	8,267	8,100	8,302
Cost of Sales, Excl. D&A($M)	4,962	4,861	4,523	4,547	4,379	4,306	4,157	4,320	4,356	4,251	4,216	4,431
Selling, General & Administrative Expense($M)	892	891	893	880	897	870	786	814	823	840	860	832
Research & Development Expense($M)	37	37	38	35	36	38	38	39	37	36	38	39
Depreciation & Amortization (GAAP)($M)	965	963	951	950	961	942	910	913	960	958	949	949
Operating Profit (GAAP)($M)	2,150	2,554	2,439	2,018	2,367	2,354	2,184	2,270	2,086	2,184	2,095	2,028
Interest Expense — Net($M)	71	61	62	64	64	67	60	53	68	70	65	71
Income from Equity Investments($M)	61	36	40	43	36	33	38	39	38	45	48	39
Income Before Income Taxes & Equity Investments($M)	2,128	2,546	2,431	2,011	2,360	2,346	2,180	2,263	2,063	2,163	2,080	1,996
Income Taxes (GAAP)($M)	449	610	571	481	424	573	511	533	498	508	463	459
Net Income — Consolidated (Incl. Noncontrolling Interests)($M)	1,740	1,972	1,900	1,573	1,972	1,806	1,707	1,769	1,603	1,700	1,665	1,576
Noncontrolling Interests Income($M)	48	44	43	43	43	40	34	44	53	37	38	33
Net Income — Linde plc($M)	1,692	1,928	1,857	1,530	1,929	1,766	1,673	1,725	1,550	1,663	1,627	1,543
Diluted EPS (GAAP)($)	3.66	4.15	3.98		4.09	3.73	3.51		3.22	3.44	3.35
Dividends Declared per Ordinary Share($)	1.60	1.60	1.60	1.50	1.50	1.50	1.50	1.39	1.39	1.39	1.39	1.27
Weighted-Average Diluted Shares(M)	463	465	466		472	474	476		481	483	486
Total Assets (DB Balance Sheet)($M)7	88,075	88,349	86,315	86,817	85,993	86,078	82,704	80,147	82,546	80,215	80,347	80,811
Cash & Cash Equivalents($M)	3,947	4,898	3,959	5,056	4,509	4,786	5,294	4,850	5,187	4,626	4,848	4,664
Accounts Receivable — Net($M)	5,595	5,632	5,321	4,966	5,331	5,230	4,950	4,622	4,871	5,001	5,009	4,718
Goodwill($M)	27,900	27,927	27,882	27,927	27,828	27,812	26,507	25,937	27,108	26,365	26,289	26,751
Accounts Payable($M)	2,854	2,837	2,659	2,810	2,646	2,593	2,446	2,507	2,845	2,859	2,885	3,020
Long-Term Debt($M)	20,593	20,678	19,859	20,683	18,592	19,701	17,608	15,343	17,475	16,931	15,227	13,397
Linde plc Shareholders' Equity($M)	39,422	39,081	38,566	38,245	38,616	38,515	38,032	38,092	39,173	38,179	38,829	39,720
Noncontrolling Interests (Balance Sheet)($M)	1,563	1,536	1,513	1,483	1,457	1,458	1,418	1,383	1,417	1,359	1,387	1,362
Operating Cash Flow (DB Cash Flow Statement)($M)3	3,169	2,271	2,240	3,030	2,948	2,211	2,161	2,809	2,731	1,929	1,954	2,727
Capital Expenditures (DB)($M)	1,392	1,438	1,342	1,458	1,276	1,257	1,270	1,250	1,066	1,133	1,048	1,151
Cash Dividends Paid($M)	735	738	741	698	701	704	708	659	662	665	669	616
Acquisitions — Net of Cash Acquired($M)	26	232	153	19	123	158	112	142	23	152	0	111
DB Legacy Segment D&A & CapEx Reference (through FY2026Q2 — Americas D&A)($M)3		388	379	383	380	374	367	359	361	372	358
EMEA Segment D&A (DB)($M)		175	175	177	176	169	159	161	163	157	159
APAC Segment D&A (DB)($M)		176	174	173	171	168	162	154	165	160	162
Engineering Segment D&A (DB)($M)		8	7	8	8	8	8	9	8	8	8

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics

Fiscal Calendar & Latest Period: Linde plc (LIN) reports on a calendar fiscal year ending December 31; latest reported quarter is FY2026Q3 (ended September 30, 2026, Form 10-Q & 3Q26 Earnings Release filed October 29, 2026).
Q3 2026 Segment Recast (Americas -> Global Other): In Q3 2026, Linde moved its U.S. homecare business (Lincare) from Americas to Global Other. Group 5 presents full recast Segment Sales & Operating Profit across FY2024, FY2025Q1–Q4, FY2025, and FY2026Q1–Q3 (filling the FY2026Q3 DB segment_values gap), while pre-recast Americas/Other series through FY2026Q2 are labeled Legacy Basis.
Allowed Period Splits Only (RULES.md Bước 4): Q4 disaggregated distribution-mode sales (Group 3) and FY2025Q4 Linde Bangladesh P&L (Group 8) are split via FY − 9M strictly on matching accounting bases; cash flow items in DB use YTD − prior YTD. Zero self-computed ratios, margins, YoY %, or Q1–Q4 sums are generated.
Consolidated − Standalone Assessment (RULES.md Bước 3): Although Linde plc files Irish Statutory Financial Statements containing a Parent Company Balance Sheet, Linde plc is a pure holding company without industrial gas plants or third-party operating revenue; therefore Consolidated − Standalone subtraction is not performed, and standalone operating subsidiaries (Linde Bangladesh, Linde India, BOC Limited UK) are presented directly in Group 8.

Not shown because recent periods are missing (13)

Industry Benchmarks › Industrial Gas End-Market Activity — U.S. Manufacturing IP (2017=100) › U.S. Manufacturing Construction Spending (SAAR)
DB Context › Geographic Revenue by Country — United States (Annual 10-K) › Country Revenue — Europe Excl. Germany & UK
DB Context › Geographic Long-Lived Assets by Country — United States (Annual 10-K) › Long-Lived Assets — Europe Excl. Germany & UK
Americas & Global Other Disaggregated Distribution Mode (Recast 3Q26 Basis) — Q3 2026 Form 10-Q only provides recast Distribution Mode for 3Q26, 3Q25, 9M26 and 9M25 (not discrete 1Q26 and 2Q26), failing the 3-consecutive-quarter rule; full recast Segment Sales & Operating Profit (1Q25–3Q26) are included in Group 5 and 18-quarter Legacy Distribution Mode (1Q22–2Q26) in Group 3
Weighted Operating Margins Excl. Cost Pass-Through YoY (bps, Slide 4) — only tabulated in consistent multi-segment format in 2Q26 and 3Q26 slide decks (2 quarters < 3 required)
Pre-Merger Historical Praxair / Linde AG Legacy Segments (NorthAmericaSegment, SouthAmericaSegment, EuropeSegment, AsiaSegment, SurfaceTechnologiesSegment, LindeAGSegment) — discontinued upon the October 2018 merger / 2019 segment realignment
Linde plc Irish Statutory Parent-Only Balance Sheet Subtraction (Consolidated − Parent) — Linde plc is a pure holding company with zero industrial gas plant operations or third-party gas revenue, failing RULES.md Bước 3 substance test
90 Bound / Approximate Callouts in Transcripts, Slides & Reports ('over 50 clean energy projects', 'more than $10 billion', 'approximately half of RPO in 6 years', '~7,000 drivers') — excluded per RULES.md Bước 5 (no bound numbers)
DB gross-profit: FY2017 (revenue − cost-of-revenue), FY2018Q1 (revenue − cost-of-revenue), FY2018Q2 (revenue − cost-of-revenue), FY2018Q3 (revenue − cost-of-revenue)
DB eps-diluted: FY2018Q4 (net-income / shares-diluted), FY2019Q4 (net-income / shares-diluted), FY2020Q4 (net-income / shares-diluted), FY2021Q4 (net-income / shares-diluted)
DB shares-diluted: FY2020Q4 (4×FY − (3×9M)), FY2021Q4 (4×FY − (3×9M)), FY2022Q4 (4×FY − (3×9M)), FY2023Q4 (4×FY − (3×9M))
DB total-debt: FY2017 (current-debt + long-term-debt), FY2017Q4 (current-debt + long-term-debt), FY2018 (current-debt + long-term-debt), FY2018Q4 (current-debt + long-term-debt)
DB free-cash-flow: FY2016 (operating-cash-flow + capital-expenditure), FY2017 (operating-cash-flow + capital-expenditure), FY2018Q1 (operating-cash-flow + capital-expenditure), FY2018Q2 (operating-cash-flow + capital-expenditure)

Data updated 2026-10-31.

Every KPI on its own page

Full history, chart, sources and a citation for each metric

Linde PLC (LIN) operating KPIs

KPIs

Every KPI on its own page

1. Project Backlog (Sale of Gas vs. Sale of Plant), RPO, Engineering Intake & CapEx Split (Core Key 1)

2. Underlying Sales Growth Drivers — Volume, Price/Mix, Cost Pass-Through & FX (Core Key 2)

3. Disaggregated Sales by Distribution Mode (Packaged Gas, Merchant, On-Site, Other) × Geography (Core Key 3)

4. Global End-Market Mix & Organic Growth (Chemicals & Energy, Manufacturing, Healthcare, Metals, Electronics, Food & Bev) (Core Key 4)

5. Return on Capital (ROC %), Q3 2026 Recast Segments, Non-GAAP Reconciliations & EPS Guidance

6. Production Infrastructure (PP&E by Asset Class), Inventory, Leases, Debt/Tax/Pension, Workforce & 3TG Supply Chain

7. Sustainable Development — ASU Power, SMR Hydrogen Emissions, Customer GHG Avoided, Water & Safety (ESG 2018–2025)

8. Self-Reported Public & Operating Subsidiaries (Linde Bangladesh, Linde India, BOC Limited UK)

9. Industrial Gas Molecule Prices, Chemical Capacity Utilization, SMR NatGas & ASU Power Benchmarks (Monthly)

10. Country Geography, GAAP Financial Statements & Legacy Segment Context (PostgreSQL DB)